Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging
Abstract
Using magnetic resonance diffusion tensor imaging (DTI), the present study investigates changes in both gray and white matter in the APPsw transgenic mouse (Tg2576), a model of beta-amyloid plaque deposition associated with Alzheimer's disease (AD). DTI analyses were performed in cross-sectional groups of transgene-positive and -negative mice at 8, 12, 16, and 18 months of age to assess the magnitude of water diffusion in gray matter (i.e., Tr(D)) and changes in diffusion in white matter that may be indicative of axonal degeneration (i.e., reduced water diffusion parallel to axonal tracts, lambda(||)) and myelin degradation (i.e., increased water diffusion perpendicular to axonal tracts, lambda(perpendicular)). No appreciable changes in gray or white matter were observed between the APPsw and the age-matched control mice at 8 months of age. Reduced Tr(D) and lambda(||) were observed in gray and white matter, respectively, for the APPsw mice at ages greater than 8 months, which coincides with the time period when appreciable amyloid plaque accumulation was confirmed by ex vivo histopathological studies. The decreases in lambda(||) suggest the presence of axonal injury in multiple white matter tracts of APPsw mice. Unlike lambda(||), lambda(perpendicular) was unaltered between control and APPsw mice in most white matter tracts. However, in the corpus collosum (CC), lambda(perpendicular) increased at 16 and 18 months of age, suggesting the possibility of myelin damage in the CC…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The effects of amyloid plaques have been investigated in previous studies where differences in DTI parameters have been observed at late time points after the appearance of amyloid plaques.
“The effects of amyloid plaques, the other hallmark pathology of AD, have been investigated in previous studies (Song et al., 2004, Sun et al., 2005) where differences in DTI parameters have been observed at late time points after the appearance of amyloid plaques.”
From In vivo imaging of tau pathology using multi-parametric quantitative MRI (2015) · cites this paper as Sun et al., 2005
Degeneration could be initiated through synaptic or axonal mechanisms, independent of apoptosis.
“These observations raise the prospect that degeneration could be initiated through synaptic or axonal mechanisms, independent of apoptosis, a mechanism which has been widely studied in other model systems, such as spinal cord injury and Multiple Sclerosis 59–61.”
From Amyloid-beta induced retrograde axonal degeneration in a mouse tauopathy model (2019) · cites this paper as [61]
The authors' dMRI results are generally consistent with those reported using other mouse models of AD.
“Our dMRI results are generally consistent with those reported using other mouse models of AD [31–35].”
From Brain microstructure abnormalities in the 3xTg-AD mouse – A diffusion MRI and morphology correlation study (2022) · cites this paper as [32]
The citation lists haven’t been fetched yet
References 46 · Cited by 121
- Authors
- Sun, S.-W., Song, S.-K., Harms, M. P., Lin, S.-J., Holtzman, D. M., Merchant, K. M., & Kotyk, J. J.
- Affiliations
- Washington University in St. Louis (US)
- Pfizer (United States) (US)
- Corresponding author
- Kotyk, John J.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 191
- Issue
- 1
- Pages
- 77-85
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2050633133
- Cited by
- 121
- References
- 46
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 2 · 2016: 4 · 2015: 8 · 2014: 8 · 2013: 16 · 2012: 8
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P50AG05681)
- National Cancer Institute (1 R24 CA83060-01)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cerebral amyloidosis, diffusion tensor imaging, axonal degeneration, myelin degradation, corpus callosum, gray matter, white matter, amyloid plaques, water diffusion
- MeSH terms
- Aging, Alzheimer Disease, Amyloidosis, Animals, Brain, Brain Injuries, Disease Models, Animal, Female, Male, Mice, Transgenic, Diffusion Magnetic Resonance Imaging, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review